Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cardiome Pharma Corp (CRME)

Cardiome Pharma Corp (CRME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cardiome Pharma Corp 1441 Creekside Drive 6th Floor Vancouver A1 V6J 4S7 CAN

www.cardiome.com P: 604-677-6905

Description:

Cardiome Pharma Corp. is a product-focused cardiovascular drug development company with two clinical drug programs focused on atrial arrhythmia (intravenous and oral dosing), and a pre-clinical program directed at improving cardiovascular function.

Key Statistics

Overview:

Market Capitalization, $K 81,247
Shares Outstanding, K 34,870
Annual Sales, $ 24,010 K
Annual Net Income, $ -29,810 K
Last Quarter Sales, $ 7,030 K
Last Quarter Net Income, $ -8,340 K
60-Month Beta 0.19
% of Institutional Shareholders 50.49%

Growth:

1-Year Return -31.87%
3-Year Return -75.03%
5-Year Return 20.10%
5-Year Revenue Growth 2,978.21%
5-Year Earnings Growth -43.75%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.20 on 11/14/17
Next Earnings Date 05/15/18
Earnings Per Share ttm -0.90
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -20.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 04/12/13

CRME Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -139.99%
Return-on-Assets % -45.80%
Profit Margin % -124.16%
Debt/Equity 2.47
Price/Sales 3.46
Price/Cash Flow N/A
Price/Book 8.94
Book Value/Share 0.47
Interest Coverage -4.17
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar